Results 241 to 250 of about 174,743 (266)

Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease.

Pediatrics, 2004
I. Ekekezie, D. Thibeault, S. Simon, M. Norberg, J. Merrill, R. Ballard, P. Ballard, W. Truog   +7 more
semanticscholar   +1 more source

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Nature Medicine, 2021
Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah   +2 more
exaly  

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.

American Heart Journal, 2001
Yoichi Inokubo, H. Hanada, H. Ishizaka, T. Fukushi, T. Kamada, K. Okumura   +5 more
semanticscholar   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Tissue Inhibitor of Metalloproteinase‐1 Is Not an Acute‐Phase Protein

Annals of the New York Academy of Sciences, 1999
P M, Timms, S, Campbell, P, Maxwell, D L, Shields, B J, Danesh   +4 more
openaire   +2 more sources

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Immunohistochemical Study of Matrix Metalloproteinase‐3 and Tissue Inhibitor of Metalloproteinase‐1 in Human Intervertebral Discs

Spine, 1996
Masakuni Kanemoto, S. Hukuda, Yasuhiro Komiya, A. Katsuura, J. Nishioka   +4 more
semanticscholar   +1 more source

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly